John McNulty

CFO attributed the moderation entirely to lapping last year's tariff-driven increases on top of the regular annual increase, not to weakening pricing power.

CEO framed the Dow partnership as normal course and described the M&A power alley qualitatively, but explicitly would not discuss anything specific in the funnel.

CFO noted things do open up in changing market conditions but too early to say. Pipelines active and exciting near-term opportunities. Staying disciplined to market-company-valuation framework.

CEO emphasized surgical pricing approach leveraging 75% direct-to-customer model for customer intimacy. Partnering with customers to offset rising costs while maintaining mid-to-high single-digit core growth discipline.

CFO cited prudent macro assumptions and In-Situ dilution mechanics: $0.02 operating earnings accretion offset by $0.04 dilution from foregone interest income on cash used. No material cost concerns otherwise.

CEO explained liquid cooling uses less but more valuable water requiring precision dosing (ChemTreat), continuous monitoring of ultra-low range organics (Hach), and high-purity disinfection (Trojan). All three businesses benefit regardless of water temperature.

CFO highlighted strong cash generation and balance sheet position. Pipelines active with disciplined market-company-valuation framework. Committed to deploying capital to create long-term shareholder value.

CEO noted strong price execution with balanced price-volume contribution in Water Quality. Pricing framework of 100-200 basis points contribution expected to continue. Strong pricing position expected in Q4.

CFO noted strong operating earnings driving FCF, year-to-date over 100% conversion but maintaining 90-100% full year guide. CEO described M&A pipelines as active and full with mosaic of targets, but valuations remain slightly elevated.

CEO confirmed deep dive showed no evidence of pre-buying. 75% direct-to-end-user sales provide visibility. Q3 orders off to good start with nothing unusual. CFO noted raised core growth guide reflects volume confidence.

CFO cited volume leverage as primary Q1 margin driver. Flagged potential timing lag between tariff increases and countermeasures, continued equipment mix impact, and mathematical effect of protecting OP dollars on margin percentage.

CEO attributed strength to sustained VES momentum: commercial rearchitecting, new product development, and disciplined execution. Europe slightly better than expected on water quality.

CEO described diversified market participation and ability to pivot sales force to growth areas. Did not directly quantify share gain vs market growth contribution.

CEO noted focus on water-cooled applications with strong science team canvassing customer base. Positioned datacenters and power generation as meaningful but not singular growth drivers.

Franzen attributed the H2 acceleration mainly to ~2 points of incremental pricing lifting organic growth to ~6%.

Franzen broke down Q1 margin expansion: 50bps from favorable mix and 70bps from net productivity. Another incremental 40bps H1-to-H2 margin expansion expected. Well on track for 3-year Investor Day targets.

Koch quantified $10M Q1 water sales impact from Middle East shipping disruption. Ex-disruption, water would have been flat to slightly down. Delayed materials shipped in April. Full year water still expected up mid-single digits with H2 weighted from project timing.

Koch clarified Q4 Diversified margin expansion came from favorable line-of-business mix and productivity push, not yet from 80/20 initiatives which are still being deployed.

Koch highlighted Tyvek APX garments (best-in-class breathability + protection, rolling out globally) and gen-4 RO membrane technology (expanding capacity at Edina for 2027 commercialization with significant TCO improvement).

Koch attributed pro forma EBITDA raise to better margin and operational performance flowing through, not incremental volume upside.

Koch noted healthcare pipeline deeper due to CDMO fragmentation, majority PE-owned (easier to transact vs strategics). Water opportunities may extend beyond filtration into adjacent value chain.

Koch attributed growth to megatrends (clean water, aging population), leading market positions, and China RO share regain after 2024 destock correction.

Koch confirmed strategy team fully dedicated to M&A pipeline, separate from separation work, targeting healthcare fragmentation and Water adjacencies.

Kemp sized data center at 15% of portfolio (up mid-teens), advanced packaging at 10% (up low-20s), with growth across CMP, laminates, thermal, and EMI.

Koch attributed Water strength to favorable comps from prior destock, secular demand across RO/ion exchange, and nascent PFAS/DLE opportunities.

Koch confirmed overall 6-7% organic for ElectronicsCo, with Q1 as the highest growth quarter due to favorable comps, moderating through the year.

Koch gave a specific 2025 Water growth outlook (mid-to-high single digit) and cited secular tailwinds, filtration technology breadth, and longer-term DLE/PFAS opportunities.

Eduardo confirmed no expected gain or loss from NEOM in 2027, declining further detail due to JV confidentiality, and said APD will give a clearer annual outlook before each year as the market evolves.

Eduardo explained helium market was structurally long before conflict and expected to return. APD system designed to cover own customers but not entire market shortfall.

Eduardo provided detailed project status showing renewable power side complete. Acknowledged ammonia price spike near $1,000/ton but said too early to assess long-term impact on green ammonia demand.

Eduardo confirmed Alberta at $3.3B with first part of 2028 startup, unchanged from prior estimate. Higher certainty on scope and costs now. Offtaker negotiations continue but nothing definitive to share.

Melissa attributed margin improvement to strong on-site volumes (HyCO and non-helium merchant), strong non-helium pricing across products, partially offset by slightly higher costs. Prior year helium bulk sale drove volume comp headwind.

Melissa clarified $185-$195M is the cumulative total including prior programs. About 60% complete, with $0.40 EPS realized in FY2025 and $0.25 vs FY2024.

Eduardo candidly admitted self-inflicted issues at Alberta causing construction delays, lost weather windows, and low contractor productivity leading to cost spiral and capitalized interest.

Eduardo disclosed combined EPS from three gasification projects was near zero in FY2023-2024, well below sell-side estimates. Lu'An is the best performer.

Melissa quantified ~$75M annualized savings from 5% workforce reduction, noting ramp-up in back half of FY2025, partially offset by inflation and wage increases.

Seifi provided a clear breakdown: 1-2% price, GDP-linked volume growth, and smaller projects contributing. Acknowledged China weakness as key unknown.

Seifi clearly stated preference for offtake-linked equity partner, while noting interest from clean energy funds for pure equity participation.

Lovins quantified sequential price/cost, guided to low-single-digit inflation and price in Q3, and flagged some moderation in Solutions margin.

CEO confirmed majority of logistics decline from end-customer demand, not chip timing. Chip issue resolves by Q2 end. Wiliot investment opens ~75B unit condition monitoring TAM for food, pharma, logistics at case/pallet level; AVY becomes preferred inlay partner.

CFO explained pricing follows raw material costs while material reengineering productivity flexes cyclically to offset wage inflation in deflationary periods.

CFO confirmed HVC margins significantly above base. Gross profit margins expanded several points over recent years driven by HVC mix shift plus productivity. CEO added HVC enables portfolio resilience across cycles.

CEO confirmed growing pipeline across segments. No additional capacity needed initially for Walmart; capital reduced per billion units over last five years.

CEO detailed customer sentiment remaining muted, expecting inflationary apparel pricing in H2. Expressed strong optimism on food IL with ROIs exceeding expectations.

CFO attributed working capital to higher incentive compensation and customer rebate payments from strong 2024, not tariff pre-buying.

Management acknowledged difficulty in predicting cadence but emphasized aligned committed volumes and significant majority share position.

Beck did not break out the drivers, instead describing a business started in 2017 at less than $100 million now close to a billion and back in line with original return expectations.

Beck cited F&B United driving 5% growth in flat consumer goods market, top 35 customers growing faster than average, and agentic technology delivering remarkable savings.

Kirkland attributed Life Sciences Q4 OI softness to continued investment plus performance-based compensation comp (sales accelerated through year, driving earned comp). Full-year Life Sciences OI grew 30%. Pest benefited from favorable comp after prior-year accident spike.

Beck described pricing environment as stable. Total value delivered growing faster than pricing captured. Retention in the 90s and stable. Sees 2-3% value pricing as long-term sweet spot for the company.

Kirkland confirmed commodity inflation up low single digits including tariff impact but net DPC slightly favorable due to supply chain efficiencies. Expects low to mid-single digit commodity inflation in H2. Gross margins up 100bps in Q2.

Beck declined to share specific numbers but confirmed top 35 progressing well with best-in-class performance benchmarking approach. Productivity savings ahead of plan.

Kirkland confirmed DPC tailwinds normalized, expects low single-digit inflation in 2025 offset by supply chain efficiency.

Knavish attributed PMC strength to Asia, both marine newbuild and aftermarket stronger. Also highlighted protective coatings work for data centers (comprehensive end-to-end offering launched) and infrastructure globally. Sees PMC continuing as growth engine beyond 2026 due to strength in segments relatively unaffected by macro headwinds.

Knavish reiterated organic first but M&A not excluded. Still believes industry needs consolidation. Filter: right asset, right price, right time. Added that with undervalued stock price, buyback math often wins over acquisitions. Both organic investment, M&A, and buybacks remain on the table.

Knavish gave comprehensive refinish analysis: miles driven still climbing, accident rates okay, but insurance affordability suppressing claims (16% CAGR in premiums 2022-2024, now moderating to 3%). Industry normalization expected mid-2026. Destocking compounded by delayed claims recovery. Confident in PPG's productivity proposition attracting large potential new customers.

Knavish gave thorough breakdown: Europe missed expectations driven by Eastern Europe weakness, but Nordics/U.K./Benelux positive. Mexico retail recovered (from negative to positive low single digits) but B2B still down. Margin pressures from FX imbalance, Mexico B2B mix, Australia supply chain disruption (50bps volume hit, transitory), and divestiture above segment margin.

Knavish gave comprehensive tariff overview in 3 buckets: finished goods (minimal, local-for-local), direct cost (95%+ locally sourced, top 100 U.S. suppliers 1% China spend), and demand (each impact <1% of total sales). Morales detailed puts and takes vs January: Mexico pause and auto step-down offset by FX improvement, higher self-help, faster share gains, and quicker European stabilization.

Knavish confirmed COMEX distribution is virtually 100% domestic use in Mexico with negligible U.S. export exposure. Morales added that PMC, traffic, and refinish products are being pushed through the 5,200 concessionaire network.